Inhalation Toxicology of Ricin Preparations: Animal Models, Prophylactic and Therapeutic Approaches to Protection

REFERENCES

• Baluna R., Rizo J., Gordon B. E., Ghetie V., Vitetta E. S. Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome. Proc. Natl. Acad. Sci. USA 1999; 96(7)3957–3962
   PubMedGoogle Scholar
• Berman H. M., Westbrook J., Feng Z., Gilliland G., Bhat T. N., Weissig H., Shindyalov I. N., Bourne P. E. The Protein Data Bank. Nucleic Acids Res. 2000; 28: 235–242
   PubMed Web of Science ®Google Scholar
• Brown R. F. R., White D. E. Ultrastructure of rat lung following inhalation of ricin aerosol. Int. J. Exp. Pathol. 1997; 78(4)267–276
   PubMed Web of Science ®Google Scholar
• Cope A. C., Dec J., Cannan R. K., Renshaw B., Moore S. 1946, Ricin, Summary Technical Report of Division 9 (Chemistry), Chemical warfare agents and related problems, U.S. Defense Office of Science and Development, National Defense Research Committee, Vol. 1, pp. 179–203
   Google Scholar
• Dawson R. M., Alderton M. R., Wells D., Hartley P. G. Monovalent and polyvalent carbohydrate inhibitors of ricin binding to a model of the cell surface receptor. J. Appl. Toxicol. 2006; 26(3)247–252
   PubMedGoogle Scholar
• Doebler J. A., Wiltshire N. D., Mayer T. W., Estep J. E., Moeller R. B., Traub R. K., Broomfield C. A., Calamaio C. A., Thompson W. L., Pitt M. L. The distribution of [125I] Ricin in mice following aerosol inhalation exposure. Toxicology 1995; 98(1–3)137–149
   PubMed Web of Science ®Google Scholar
• Endo Y., Tsurugi K. RNA N-glycosidase activity of ricin A-chain; Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes. J. Biol. Chem. 1987; 262(17)8128–8130
   PubMed Web of Science ®Google Scholar
• Endo Y., Mitsui K., Motizuki M., Tsurugi K. The mechanism of action of ricin and related toxin lectins on eukaryotic ribosomes. The site and characteristics of the modification in 28S ribosomal RNA caused by the toxins. J. Biol. Chem. 1987; 262(12)5908–5912
   PubMed Web of Science ®Google Scholar
• Foxwell B. M. J., Detre S. I., Donovan T. A., Thorpe P. E. The use of anti-ricin antibodies to protect mice intoxicated with ricin. Toxicology 1985; 34(1)79–88
   PubMedGoogle Scholar
• Franz D., Jaax N. Ricin toxin. Textbook of military medicine: Part I, Medical aspects of chemical and biological warfare, R. Zajtchuk, R. F. Bellamy. Office of the Surgeon General of the Army, TMM Publications, Washington, DC 1997; 631–642
   Google Scholar
• Funatsu G., Mise T., Matsuda H., Funatsu M. Isolation and characterization of two constituent polypeptide chains of ricin E. Agric. Biol. Chem. 1978; 42(4)851–859
   Web of Science ®Google Scholar
• Griffiths G. D., Rice P., Allenby A. C., Bailey S. C., Upshall D. G. Inhalation toxicology and histopathology of ricin and abrin toxins. Inhal. Toxicol. 1994; 7(2)269–288
   Google Scholar
• Griffiths G. D., Lindsay C. D., Allenby A. C., Bailey S. C., Scawin J. W., Rice P., Upshall D. G. Protection against inhalation toxicity of ricin and abrin by immunisation. Hum. Exp. Toxicol. 1995; 14(2)155–164
   PubMedGoogle Scholar
• Griffiths G. D., Bailey S. C., Hambrook J. L., Keyte M., Jayasekera P., Miles J., Williamson E. Liposomally-encapsulated ricin toxoid vaccine delivered intratracheally elicits a good immune response and protects against a lethal pulmonary dose of ricin toxin. Vaccine 1997; 15(17–18)1933–1939
   PubMed Web of Science ®Google Scholar
• Griffiths G. D., Bailey S. C., Hambrook J. L., Keyte M. Local and systemic responses against ricin toxin promoted by toxoid or peptide vaccines alone or in liposomal formulations. Vaccine 1998; 16(5)530–535
   PubMed Web of Science ®Google Scholar
• Griffiths G. D., Phillips G. J., Bailey S. C. Comparison of the quality of protection elicited by toxoid and peptide liposomal vaccine formulations against ricin as assessed by markers of inflammation. Vaccine 1999; 17(20–21)2562–2568
   PubMed Web of Science ®Google Scholar
• Guo J.-W., Shen B.-F., Feng J.-N., Sun Y.-X., Yu M., Hu M.-R. A novel neutralizing monoclonal antibody against cell bindingpolypeptide of ricin. Hybridoma (Larchmt.) 2005; 24(5)263–266
   PubMedGoogle Scholar
• Heyder J., Gebhart J., Rudolf G., Schiller C. F., Stahlhofen W. Deposition of particles in the human respiratory tract in the size range 0.005–15 μ m. J. Aerosol. Sci. 1986; 17(5)811–825
   Web of Science ®Google Scholar
• Ishiguro M., Takahashi T., Funatsu G., Hayashi K., Funatsu M. Biochemical studies on Ricin I. Purification of ricin. J. Biochem. (Tokyo) 1964; 55: 587–592
   PubMed Web of Science ®Google Scholar
• Kende M., Yan C., Hewetson J., Frick M. A., Rill W. L., Tammariello R. Oral immunization of mice with ricin toxoid vaccine encapsulated in polymeric microspheres against aerosol challenge. Vaccine 2002; 20(11–12)1681–1691
   PubMed Web of Science ®Google Scholar
• Kende M., Del Giudice G., Rivera N., Hewetson J. Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant. Vaccine 2006; 24(12)2213–2221
   PubMed Web of Science ®Google Scholar
• Kende M., Tan X., Wlazlowski C., Williams R., Lindsey C., Del Giudice G. Enhancement of intranasal vaccination with recombinant chain A ricin vaccine (rRV) in mice by mucosal adjuvants LTK63 and LTR72. Vaccine 2007; 25(16)3219–3227
   PubMedGoogle Scholar
• Lee C., Watt K. C., Chang A. M., Plopper C. G., Buckpitt A. R., Pinkerton K. E. Site selective differences in cytochrome P450 isoform activities. Comparison of expression in rat and rhesus monkey lung and induction in rats. Drug. Metab. Dispos. 1998; 26(5)396–400
   PubMedGoogle Scholar
• Leong K. H., Wang H. C., Stukel J. J., Hopke P. K. An improved constant output atomiser. Am. Ind. Hyg. Assoc. J. 1982; 43: 135–136
   Web of Science ®Google Scholar
• Lin J. Y., Liu K., Chen C.-C., Tung T.-C. Effect of crystalline ricin on the biosynthesis of protein, RNA and DNA in experimental tumor cells. Cancer Res. 1971; 31(7)921–924
   PubMedGoogle Scholar
• Lin T. T.-S., Li S. S.-L. Purification and physicochemical properties of ricins and agglutinins from Ricinus communis. Eur. J. Biochem. 1980; 105(3)453–459
   PubMedGoogle Scholar
• Liu B. Y. H., Lee K. W. An aerosol generator of high stability. Am. Ind. Hyg. Assoc. J. 1975; 36(12)861–865
   PubMed Web of Science ®Google Scholar
• Lord J. M., Gould J., Griffiths D., O'Hare M., Prior B., Richardson P. T., Roberts L. M. Ricin: Cytotoxicity, biosynthesis and use in immunoconjugates. Prog. Med. Chem. 1987; 24: 1–28
   PubMedGoogle Scholar
• Lord J. M., Hartley M. R., Roberts L. M. Ribosome inactivating proteins in plants. Semin. Cell Biol. 1991; 2(1)15–22
   PubMedGoogle Scholar
• Lord J. M., Roberts L. M., Lencer W. I. Entry of protein toxins into mammalian cells by crossing the endoplasmic reticulum membrane: Co-opting basic mechanisms of endoplasmic reticululm-associated degradation. Curr. Top. Microbiol. Immunol. 2005; 300: 149–168
   PubMed Web of Science ®Google Scholar
• Marsden C. J., Knight S., Smith D. C., Day P. J., Roberts L. M., Phillips G. J., Lord J. M. Insertional mutagenesis of ricin A chain: a novel route to an anti-ricin vaccine. Vaccine 2004; 22(21–22)2800–2805
   PubMedGoogle Scholar
• Mise T., Funatsu G., Ishiguro M., Funatsu M. Isolation and characterization of ricin E from castor beans. Agric. Biol. Chem. 1977; 41(10)2041–2046
   Web of Science ®Google Scholar
• Nicolson G. L., Blaustein J. The interaction of Ricinus communis agglutinin with normal and tumour cell surfaces. Biochim. Biophys. Acta 1972; 266(2)543–547
   PubMedGoogle Scholar
• Olsnes S., Pihl A. Abrin, ricin and their associated agglutinins. The specificity and action of animal, bacterial and plant toxins: Receptors and recognition, Series B, Vol. 1, P. Cuatrecasas. Chapman and Hall, London 1976; 129–173
   Google Scholar
• Olsnes S., Pihl A. Toxic lectins and related proteins. Molecular action of toxins and viruses, P. Cohen, S. van Heyningen. Elsevier, Amsterdam 1982; 51–105
   Google Scholar
• Olson M. A., Carra J. H., Roxas-Duncan V., Wannemacher R. W., Smith L. A., Millard C. B. Finding a new vaccine in the ricin protein fold. Protein Eng. Des. Sel. 2004; 17(4)391–397
   PubMed Web of Science ®Google Scholar
• Paddle B. M. Therapy and prophylaxis of inhaled biological toxins (Review article). J. Appl. Toxicol. 2003; 23(3)139–170
   PubMedGoogle Scholar
• Perentesis J. P., Miller S. P., Bodley J. W. Protein toxic inhibitors of protein synthesis. Biofactors 1992; 3(3)173–184
   PubMedGoogle Scholar
• Phillips G. J., Knight S., Hornby R., Wilkinson L., Platt J., Hughes N., Griffiths G. Comparison of the protective efficacies of several ricin vaccine candidates: Immunological characterisation and quality of protection, In preparation
   Google Scholar
• Plopper C. G., Harkema J. R. Respiratory system. The laboratory primate handbook of experimental animals, S. Woolfe-Coote. Elsevier Academic Press, London 2005; 503–522
   Google Scholar
• Poli M. A., Rivera V. R., Pitt M. L., Vogel P. Aerosolized specific antibody protects mice from lung injury associated with aerosolized ricin exposure. Toxicon 1996; 34(9)1037–1044
   PubMedGoogle Scholar
• Poole S. J. C., Veall S. M., Holley J. L., Simpson A. J. H. The production and evaluation of ricin antitoxins. Toxicon 2006
   Google Scholar
• Raabe O. G., Al-Bayati M., Teague S. V., Rasolt A. Regional deposition of inhaled monodisperse coarse and fine aerosol particles in small laboratory animals. Ann. Occup. Hyg. 1988; 32: 53–63, (suppl. 1)
   Google Scholar
• Roy C. J., Hale M., Hartings J. M., Pitt L., Duniho S. Impact of inhalation exposure modality and particle size on the respiratory deposition of ricin in BALB/c mice. Inhal. Toxicol. 2003; 15(6)619–638
   PubMed Web of Science ®Google Scholar
• Rutenber E., Katzin B. J., Ernst S., Collins E. J., Mlsna D., Ready M. P., Robertus J. D. Crystallographic refinement of ricin to 2.5 angstroms. Proteins Struct. Funct. 1991; 10: 240–259
   PubMed Web of Science ®Google Scholar
• Schreider J. P. Nasal airway anatomy and inhalation deposition in experimental animals and people. Nasal tumours in animals and man, Vol. III. Experimental nasal carcinogenesis, G. Reznik, S. F. Stinson. CRC Press, Boca Raton, FL 1983; 1–26
   Google Scholar
• Sipes I. G., Gandolfi A. J. Biotransformation of toxicants. Casarett and Doull's toxicology; The basic science of poisons, 4th ed., M. O. Amdur, J. Doull, C. D. Klaassen. Pergamon Press. 1991; 88–126
   Google Scholar
• Smallshaw J. E., Firan A., Fulmer J. R., Ruback S. L., Ghetie V., Vitetta E. S. A novel recombinant vaccine which protects mice against ricin intoxication. Vaccine 2002; 20(27–28)3422–3427
   PubMed Web of Science ®Google Scholar
• Smallshaw J. E., Ghetie V., Rizo J., Fulmer J. R., Trahan L. L., Ghetie M. A., Vitetta E. S. Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice. Nat. Biotechnol. 2003; 21(4)387–391
   PubMed Web of Science ®Google Scholar
• Smallshaw J. E., Richardson J. A., Pincus S., Schindler J., Vitetta E. S. Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin. Vaccine 2005; 23(39)4775–4784
   PubMed Web of Science ®Google Scholar
• Soler-Rodriguez A. M., Ghetie M. A., Oppenheimer-Marks N., Uhr J. W., Vitetta E. S. Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: Implications for vascular leak syndrome. Exp. Cell Res. 1993; 206(2)227–234
   PubMedGoogle Scholar
• Stirpe F., Battelli M. G. Ribosome-inactivating proteins: progress and problems. Cell. Mol. Life Sci. 2006; 63(16)1850–1866
   PubMedGoogle Scholar
• Stirpe F., Barbieri L. Ribosome-inactivating proteins to date. FEBS Lett. 1986; 195(1–2)1–8
   PubMedGoogle Scholar
• Stirpe F., Barbieri L., Batelli M. G., Soria M., Lappi D. A. Ribosome-inactivating proteins from plants: Present status and future prospects. Biotechnology (NY) 1992; 10(4)405–412
   PubMedGoogle Scholar
• Vitetta E. S., Smallshaw J. E., Coleman E., Jafri H., Foster C., Munford R. A. Pilot clinical trial of a recombinant ricin vaccine in normal humans. Proc. Natl. Acad. Sci. USA 2006; 103: 2268–2273
   PubMed Web of Science ®Google Scholar
• Wang S., Feng J., Guo J., Guo Leiming G., Li Y., Sun Y., Qin W., Hu M., Han G., Shen B. A novel designed single domain antibody on 3-D structure of ricin A chain remarkably blocked ricin-induced cytotoxicity. Mol. Immunol. 2006; 43: 1912–1919
   PubMedGoogle Scholar
• Wannemacher R. W., Anderson J. B. Inhalation ricin: Aerosol procedures, toxicology and therapy. Inhalation toxicology, 2nd ed., H. Salem, S. Katz. CRC Taylor & Francis, Boca Raton, FL 2006; 973–980
   Google Scholar
• Wilhelmsen C. L., Pitt M. L. M. Lesions of acute inhaled lethal ricin intoxication in rhesus monkeys. Vet. Pathol. 1996; 33(3)296–302
   PubMed Web of Science ®Google Scholar
• Yan C., Rill W. L., Malli R., Hewetson J., Naseem H., Tammariello R., Kende M. Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid vaccine encapsulated in polymeric microspheres. Vaccine 1996; 14(11)1031–1038
   PubMed Web of Science ®Google Scholar